The COVID-19 pandemic has seen a surge of patients with acute respiratory distress
syndrome (ARDS) in intensive care units across the globe. As experience of managing …

Acute respiratory distress syndrome (ARDS) is a complex syndrome of acute lung injury
leading to noncardiogenic pulmonary edema from many causes that is heterogenous in its …

Abstract SARS-CoV-2, the etiologic agent of COVID-19, is a global pandemic with
substantial mortality dominated by acute respiratory distress syndrome. We systematically …

Background Little is known about the practice of ventilation management in patients with
COVID-19. We aimed to describe the practice of ventilation management and to establish …

Rationale: Clinical and epidemiologic data in coronavirus disease (COVID-19) have
accrued rapidly since the outbreak, but few address the underlying pathophysiology …

Purpose To investigate whether COVID-19-ARDS differs from all-cause ARDS. Methods
Thirty-two consecutive, mechanically ventilated COVID-19-ARDS patients were compared to …

Background The mortality of critically ill patients with COVID-19 is high, particularly among
those receiving mechanical ventilation (MV). Despite the high number of patients treated …

Aims Diffuse alveolar damage (DAD) is a ubiquitous finding in inpatient coronavirus disease
2019 (COVID‐19)‐related deaths, but recent reports have also described additional atypical …

Rationale: There is an urgent need for improved understanding of the mechanisms and
clinical characteristics of acute respiratory distress syndrome (ARDS) due to coronavirus …

Objectives: Increasing time to mechanical ventilation and high-flow nasal cannula use may
be associated with mortality in coronavirus disease 2019. We examined the impact of time to …